Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
about
Rational modulation of the innate immune system for neuroprotection in ischemic strokeCytokines: their role in stroke and potential use as biomarkers and therapeutic targetsAdrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after strokePost-stroke infection: a role for IL-1ra?Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharideSerum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volumeStress mediators and immune dysfunction in patients with acute cerebrovascular diseases.The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.Peripheral administration of human adrenomedullin and its binding protein attenuates stroke-induced apoptosis and brain injury in rats.Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage.Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection.Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhageMolecular biomarkers in stroke diagnosis and prognosis.Potential specific immunological indicators for stroke associated infection are partly modulated by sympathetic pathway activation.Inflammatory cytokines in experimental and human stroke.The immune system in stroke: clinical challenges and their translation to experimental research.Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Infection and Stroke: an Update on Recent Progress.Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations.Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
P2860
Q26851831-337E8607-8B77-4153-875D-ED82EA263F4BQ26998414-8A88A6E3-30BB-46AD-AF2F-3949E2FEA0BEQ30846614-92539751-42B8-423B-83EA-329FCBCB6954Q33897235-D41CD961-7E43-4DD9-B331-D337D403E5E6Q34286778-8BBDD5E6-6FD7-407D-BAE1-AF0FFEF98DE0Q34729372-0D6CDD87-D365-490B-B2E7-7F0C97B79A21Q34999360-DE10E135-9CAB-40D6-9B34-A0A9013AC640Q35154166-8E56C8F1-FD7A-4E47-92C2-0436F5E51CDDQ35195927-22888D1F-6A6C-4CFF-BDF6-FE16D129C5EDQ35286918-9D72D0DD-A5C1-4133-B30F-78E534A5B6D6Q35412740-34440678-C34D-446B-AE89-F91CFFDABD28Q35553390-1BE6A25D-20B8-4360-8341-B8B746FEECB8Q36478414-D4570F7D-0FCD-4EAC-97E3-03116EF9F433Q37206108-CF11B408-16E0-400A-B14E-61565BD520F5Q37267691-885943B5-FCF8-4DA8-A52D-4B9E8C5567F3Q37408830-1FB7E4ED-0BBA-4DB7-85D8-112F644CCB5AQ37588473-B8AE6A10-4D81-48E7-A4B8-30F66A2A02CEQ38022155-2E75CB5D-F559-4027-BFFA-04333655FF5AQ38106872-D23F4042-6CA6-4377-833D-99F3EAF4DC9AQ38366399-5FAACF26-DF29-4EFC-ACAC-8A80E065E955Q38671800-278F53BE-6675-46DF-8D63-66E727D94611Q47573293-CB92AA8D-3F82-46AB-A9DD-77A38DC02092Q58799486-6F08C322-E305-492A-AF6E-5E4CF442BAE5
P2860
Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical outcome following acu ...... bition of cytokine production.
@ast
Clinical outcome following acu ...... bition of cytokine production.
@en
Clinical outcome following acu ...... bition of cytokine production.
@nl
type
label
Clinical outcome following acu ...... bition of cytokine production.
@ast
Clinical outcome following acu ...... bition of cytokine production.
@en
Clinical outcome following acu ...... bition of cytokine production.
@nl
prefLabel
Clinical outcome following acu ...... bition of cytokine production.
@ast
Clinical outcome following acu ...... bition of cytokine production.
@en
Clinical outcome following acu ...... bition of cytokine production.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinical outcome following acu ...... bition of cytokine production.
@en
P2093
Carole M Gavin
Elisa M Barberan
Hedley C A Emsley
Margaret E Hoadley
Nancy J Rothwell
Rachel F Georgiou
Sylvia Scarth
Vijitha Wickramasinghe
P2860
P2888
P356
10.1186/1471-2377-7-5
P577
2007-02-28T00:00:00Z
P5875
P6179
1004179916